Labcorp to announce first quarter financial results on April 28, 2022

BURLINGTON, N.C. --(BUSINESS WIRE)--Mar. 28, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, will release its financial results for the first quarter of 2022 before the market opens on Thursday, April 28, 2022 . The company will host a conference call and webcast.

New Labcorp offering makes detecting, measuring unintentional gluten consumption simple and effective

Labcorp becomes first U.S. commercial laboratory to provide quantitative testing for gluten in stool samples BURLINGTON, N.C. --(BUSINESS WIRE)--Mar. 17, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, is the first U.S. commercial laboratory to offer a new test developed by Immundiagnostik, Inc.

Report on data interoperability measures will be released at HIMSS22

WASHINGTON, March 14, 2022 — The Healthcare Leadership Council (HLC) will release a report on how to better measure progress toward health data interoperability at a March 16 breakfast event, hosted by Surescripts, in conjunction with the HIMSS Global Health Conference in Orlando, FL.

Labcorp enters into strategic relationship with Prisma Health

BURLINGTON, N.C. --(BUSINESS WIRE)--Mar. 9, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, is entering into a strategic laboratory relationship with Prisma Health , a nonprofit and the largest health system in South Carolina.

Walgreens and Labcorp offer at-home COVID-19 PCR test collection kits at no cost nationwide

Collaboration expands access to convenient testing at no cost for eligible individuals DEERFIELD, Ill., and BURLINGTON, N.C., March 7, 2022 – Walgreens and Labcorp, a leading global life sciences company, today announced the nationwide [i] availability of Pixel by Labcorp® [ii] COVID-19 at-home collection kit, a PCR test available through Labcorp OnDemand™, at no cost to individuals who meet clinical guidelines*.